Kamal Sanaa M, Amin Ashraf, Madwar Mohamed, Graham Camilla S, He Qi, Al Tawil Ahmed, Rasenack Jens, Nakano Tatsunori, Robertson Betty, Ismail Alaa, Koziel Margaret James
Department of Infectious Diseases, Harvard Institutes of Medicine, 4 Blackfan Circle, Boston, MA 02115, USA.
J Virol. 2004 Nov;78(22):12252-8. doi: 10.1128/JVI.78.22.12252-12258.2004.
Acute hepatitis C virus (HCV) is typically defined as new viremia and antibody seroconversion. Rates and immunologic correlates of hepatitis C clearance have therefore been based on clearance of viremia only in individuals who initially had an antibody response. We sought to characterize the immunological correlates of clearance in patients with acute hepatitis C and their sexual contacts. We prospectively determined CD4(+) and CD8(+) cytotoxic T-lymphocyte responses in index patients with acute HCV and their sexual contacts who developed acute infection, either with or without spontaneous clearance, as well as those contacts who never developed viremia. Responses were measured using proliferation and ELISpot assays for CD4(+) and CD8(+) responses. We demonstrate in this prospective study that cellular immune responses can develop in exposed but persistently aviremic and antibody-negative individuals as well as those individuals with spontaneous clearance of acute HCV. These findings lend further credence to the importance of cellular immune responses in recovery from HCV and suggest that low exposure to HCV may lead to development of HCV-specific immune responses without ongoing HCV replication. This finding has important implications for HCV vaccine and therapeutic development.
急性丙型肝炎病毒(HCV)感染通常定义为新发病毒血症和抗体血清学转换。因此,丙型肝炎病毒清除率及其免疫相关因素仅基于最初出现抗体反应的个体的病毒血症清除情况。我们试图明确急性丙型肝炎患者及其性接触者中病毒清除的免疫相关因素。我们前瞻性地测定了急性丙型肝炎病毒感染的索引患者及其性接触者的CD4(+)和CD8(+)细胞毒性T淋巴细胞反应,这些性接触者无论是发生急性感染(无论是否自发清除病毒),还是从未发生病毒血症。使用增殖试验和ELISpot试验检测CD4(+)和CD8(+)反应。我们在这项前瞻性研究中证明,在暴露但持续无病毒血症且抗体阴性的个体以及急性丙型肝炎病毒自发清除的个体中均可产生细胞免疫反应。这些发现进一步证明了细胞免疫反应在丙型肝炎病毒感染恢复中的重要性,并表明低水平的丙型肝炎病毒暴露可能导致丙型肝炎病毒特异性免疫反应的产生,而无需持续的丙型肝炎病毒复制。这一发现对丙型肝炎病毒疫苗和治疗的研发具有重要意义。